Rilmenidine is an oxazoline derivative and an imidazoline I1-receptor agonist primarily indicated for the treatment of essential hypertension. By stimulating both central and peripheral vasomotor structures,… Read more
















Rilmenidine is an oxazoline derivative and an imidazoline I1-receptor agonist primarily indicated for the treatment of essential hypertension. By stimulating both central and peripheral vasomotor structures, this medication effectively lowers blood pressure, offering a therapeutic option for cases often resistant to other antihypertensive agents. This category offers high-quality reference standards for Rilmenidine, encompassing its active pharmaceutical ingredient, pharmacopeial impurities such as Impurity A and Impurity B, and other related degradation products. These materials are essential for pharmaceutical laboratories performing rigorous impurity profiling, method validation, and routine quality control. Additionally, researchers rely on stable isotope-labelled compounds, including Rilmenidine-d4, to serve as internal standards in quantitative analytical testing. By utilizing these specialized reference materials, analysts can ensure accurate detection and quantification of related substances, supporting the development and monitoring of consistent pharmaceutical formulations.